4//SEC Filing
HOLMLUND JON T 4
Accession 0000899243-20-027723
CIK 0001563577other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 5:01 PM ET
Size
17.7 KB
Accession
0000899243-20-027723
Insider Transaction Report
Form 4
HOLMLUND JON T
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2020-10-06$1.07/sh+4,904$5,247→ 4,904 total - Exercise/Conversion
Stock Option
2020-10-05−100→ 4,904 totalExercise: $1.07Exp: 2023-01-26→ Common Stock (100 underlying) - Exercise/Conversion
Stock Option
2020-10-06−4,904→ 0 totalExercise: $1.07Exp: 2023-01-26→ Common Stock (4,904 underlying) - Exercise/Conversion
Common Stock
2020-10-05$1.07/sh+100$107→ 100 total - Sale
Common Stock
2020-10-05$12.00/sh−100$1,200→ 0 total - Exercise/Conversion
Common Stock
2020-10-06$1.14/sh+5,632$6,420→ 5,632 total - Sale
Common Stock
2020-10-06$12.00/sh−10,536$126,432→ 0 total - Exercise/Conversion
Stock Option
2020-10-06−5,632→ 0 totalExercise: $1.14Exp: 2024-09-16→ Common Stock (5,632 underlying)
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
- [F2]The option has fully vested and is currently exercisable.
- [F3]The option has fully vested and is currently exercisable.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001227367
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 5:01 PM ET
- Size
- 17.7 KB